Re: Y-90 Medical Use

["Mike Bohan" <mike.bohan@yale.edu>]

        Reply to:   RE>Y-90 Medical Use

Ken and RadSafe,

I understand that  Y-90 is being evaluated as a source for intravascular brachytherapy.  Also, Ken, you might want to check out 10 CFR 35.  The patient release limits changed recently and the 30 mCi or 5 mR/hr @ 1 meter rule no longer is applicable.

Regards,

<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><
Michael J. Bohan, RSO   |  e-mail: mike.bohan@yale.edu
Yale-New Haven Hospital |    Tele: (203) 688-2950
Radiological Physics    |     FAX: (203) 737-4252
20 York St. - WWW 204   |    As usual, everything I say may be plausibly
New Haven, CT    06504  |    denied at my employer's convenience ...
><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>


--------------------------------------
Date: 03/05/1998 7:33 PM
To: Mike Bohan
From: radsafe@romulus.ehs.uiuc.edu
On a separate subject, I would appreciate some information regarding the use of Y-90
as a radiopharmaceutical for diagnostic or theraputic uses.  I am not familiar with its
use in medicine.  I will agree that it has been a considerable time, more that 10 years,
since I was involved in Nuclear Medicine but I still enjoy the subject.  Thanks in
advance.

Usual dislaimers, the comments are mine and not those of the agency. 
KMP@NRC.GOV